![The Collision of AI’s Machine Learning and Manipulation: Deepfake Litigation Risks to Companies from a Product Liability, Privacy, and Cyber Standpoint](https://media2.mofo.com/v3/images/blt5775cc69c999c255/blt3bcfe6e63250001a/6273148e4d9f892971290103/201217-game-growth-tech-transactions.jpg?format=auto&quality=60&width=700)
From improving genomic sequencing to discovering new drug formulations, AI plays a key role in advancing biomedical research. In particular, the field of bioinformatics, which involves the collection and interpretation of biological data using software tools, is undergoing a period of rapid transformation and growth due to innovative uses of AI. Recent AI-related developments in bioinformatics include the determination of 3D shapes of proteins, the identification of disease-specific biomarkers, and the modification of existing drugs to create COVID-19 therapeutics. This upward trend will continue throughout 2023 and beyond as AI is increasingly adopted by major biomedical research groups and biotech companies.
This post is a part of a series on trends in the artificial intelligence space for 2023, authored by MoFo lawyers.